Asianet Newsable on MSN
Triple Therapy Forces Leukemia Cells Into Necroptosis, Boosting Immune Attack
A new study finds that three existing drugs can force leukemia cells into necroptosis, activating a strong immune response.
Life is Wisdom on MSN
Beyond the Veil: 14 Unsettling Yet Utterly Fascinating Things Your Body Does After Death
The great unknown, the final frontier – death. It’s a topic shrouded in both fear and morbid curiosity, a universal ...
Gary Marcus argues today’s AI sounds smart but lacks real understanding, and says true progress needs human-like reasoning.
Study Finds on MSN
Ancient DNA Suggests Neanderthals Engaged In Kissing — And Probably Smooched Humans Too!
Neanderthals are usually seen as brutish and primitive, but research now suggests our ancestors kissed often - and even with ...
NVIDIA Corp. (NASDAQ: NVDA) released its third-quarter earnings report after Wednesday’s closing bell. The transcript from ...
BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...
A Critique of Hobbesian Premises through the Lenses of Game Theory and Evolutionary Biology The “state of war” proposed by ...
The group of researchers were the first to take snapshots of the moment naloxone reverses an opioid overdose in the brain.
Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat ...
Neuropathic pain, a chronic condition resulting from nervous system lesions or diseases, remains a formidable clinical challenge due to its complex and ...
Q3 2025 Earnings Call November 20, 2025 4:30 PM ESTCompany ParticipantsTony DammicciChristopher Marlett - Co-Founder, ...
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback